Russia's Sputnik V COVID-19 vaccine equally effective for all age groups: Developer

Mar 13, 2021

Moscow [Russia], March 14 (ANI/Sputnik): The Russian-made Sputnik V coronavirus vaccine has proven equally effective for all age groups, Alexander Gintsburg, the head of...

Russian research center suggests use of Sputnik V to boost efficacy of AstraZeneca vaccine

Nov 27, 2020

Moscow [Russia], November 27 (ANI/Sputnik): The Russian Gamaleya research institute has suggested UK pharmaceutical company AstraZeneca try to boost the efficacy of its COVID-19...

Russia's Sputnik V vaccine developer hopes to receive WHO approval before 2022

Oct 05, 2021

Moscow [Russia], October 5 (ANI/Sputnik): The developer of the Russian Sputnik V COVID-19 vaccine, Gamaleya research institute, hopes that the drug will receive necessary...

Omicron variant could replace Delta strain globally: Head of Russian Gamaleya Institute

Dec 13, 2021

Moscow [Russia], December 13 (ANI/Sputnik): The Omicron strain of the coronavirus could eventually replace the Delta variant, as it is already happening in South...

Russia develops Delta & Omicron-adapted Sputnik V vaccine

Aug 23, 2022

Moscow [Russia], August 23 : Russia's Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund announced the...

Second batch of Sputnik V coronavirus vaccine for civil circulation being produced: Gamaleya

Sep 08, 2020

Moscow [Russia], September 8 (ANI/Sputnik): The second batch of Russia's Sputnik V vaccine against COVID-19 for civil circulation is already being produced by the...